‘£200m boost’ for pharma and aerospace - Bain & Company

Bain uses cookies to improve functionality and performance of this site. More information can be found in our Privacy Policy. By continuing to browse this site, you consent to the use of cookies.

The Times

‘£200m boost’ for pharma and aerospace

  • February 06, 2017
  • min read

The Times

‘£200m boost’ for pharma and aerospace

Drug companies and aeroplane parts groups represent two of Britain's most thriving export sectors and executives in both industries had issued stark warnings about leaving the EU. However, analysis by Bain & Company finds that a hard Brexit could improve their profit margins because under World Trade Organisation rules they will be protected from tariffs.